Published in Women's Health Weekly, August 9th, 2001
Researchers in Taiwan at National Taiwan University performed the new study, evaluating levels of IL-6, vascular endothelial growth factor (VEGF), and platelet-derived growth factor (PDGF) in the cytosol of tumor specimens acquired from women with stage IB-IIA cervical cancers. Investigators detected such high levels of the cytokine in the tumors of cervical cancer patients that they predicted controlling its expression could stem or even prevent tumor growth.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.